We are live on ! Find out more
RXST icon

RxSight

164 hedge funds and large institutions have $235M invested in RxSight in 2026 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 63 increasing their positions, 54 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 54

3.35% more ownership

Funds ownership: 89.2%92.56% (+3.4%)

10% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 31

1% more funds holding

Funds holding: 163164 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

38% less capital invested

Capital invested by funds: $382M → $235M (-$147M)

81% less call options, than puts

Call options by funds: $75K | Put options by funds: $392K

Holders
164
Holders Change
+1
Holders Change %
+0.61%
% of All Funds
2.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
34
Increased
63
Reduced
54
Closed
31
Calls
$75K
Puts
$392K
Net Calls
-$317K
Net Calls Change
-$637K
Name Holding Trade Value Shares
Change
Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$1.96M +$253K +30,433 +11%
Holocene Advisors
27
Holocene Advisors
New York
$1.94M +$430K +51,830 +20%
Walleye Capital
28
Walleye Capital
New York
$1.94M +$1.88M +226,871 +259%
TAM
29
Tocqueville Asset Management
New York
$1.91M +$83K +10,000 +3%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$1.88M -$5.57M -670,956 -69%
Charles Schwab
31
Charles Schwab
California
$1.86M +$88.1K +10,608 +4%
VP
32
Vitruvian Partners
United Kingdom
$1.72M
JF
33
Jump Financial
Illinois
$1.58M +$820K +98,758 +62%
PHP
34
Parkman Healthcare Partners
Connecticut
$1.54M -$844K -101,666 -29%
BCM
35
Brown Capital Management
Maryland
$1.53M -$904K -108,817 -30%
BM
36
Bridger Management
New York
$1.53M +$732K +88,158 +55%
VFT
37
Vanguard Fiduciary Trust
Pennsylvania
$1.53M +$2.06M +247,929 New
UBS Group
38
UBS Group
Switzerland
$1.48M -$3.2M -385,144 -62%
Jane Street
39
Jane Street
New York
$1.38M -$117K -14,067 -6%
YIH
40
Y-Intercept (HK)
Hong Kong
$1.21M -$181K -21,828 -10%
Russell Investments Group
41
Russell Investments Group
United Kingdom
$1.19M +$1.04M +124,728 +180%
SSA
42
Schonfeld Strategic Advisors
New York
$1.18M -$224K -26,975 -12%
AG
43
Algert Global
California
$1.18M +$231K +27,820 +17%
SPS
44
Susquehanna Portfolio Strategies
Pennsylvania
$1.08M +$196K +23,576 +16%
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$1.03M -$426K -51,329 -23%
Canada Pension Plan Investment Board
46
Canada Pension Plan Investment Board
Ontario, Canada
$1M +$4.15K +500 +0.3%
New York State Common Retirement Fund
47
New York State Common Retirement Fund
New York
$975K
CLA
48
Carnegie Lake Advisors
New Jersey
$953K -$59K -7,100 -4%
Tudor Investment Corp
49
Tudor Investment Corp
Connecticut
$930K +$1.09M +131,655 +682%
TI
50
Trexquant Investment
Connecticut
$844K +$822K +99,004 +261%

RXST Hedge Fund Activity: Q1 2026 in Review

164 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in RxSight (RXST) for Q1 2026, worth a combined $235M — down 38% from $382M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new RXST positions and 31 closed out — a net gain of 3 holders — while 63 added to existing stakes and 54 trimmed.

The largest buyer was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, adding an estimated $8.3M. The largest seller was Defilade Capital Management, exiting entirely with an estimated $9.51M sold.

  • 164 institutional investors held RxSight (RXST) as of Q1 2026, up from 163 in Q4 2025.
  • Funds reported $235M of RxSight stock for Q1 2026, down 38% quarter-over-quarter.
  • 34 funds opened new RxSight positions in Q1 2026 and 31 closed out, a net change of +3 holders.
  • The largest RxSight buyer in Q1 2026 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $8.3M added.
  • The largest RxSight seller in Q1 2026 was Defilade Capital Management, an estimated $9.51M sold.

Based on aggregated 13F filings for Q1 2026.